CRA was retained to assess claims of “healthy antioxidants” associated with consumer products. CRA examined manufacturer pricing data and industry practice with respect to whether such claims affected prices or sales. CRA exploited variation in labeling across products and over time to examine Plaintiffs’ allegations and proposed methods to compute consumer harm.
Life Sciences Litigation Insights: March 2022
Carl Washington et al. v. CVS Pharmacy Inc., Northern District of California, No. 4:15-vc-19-03504 On June 23, 2021 a federal jury in northern California...